MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1530/eje-19-0047

Медицинская библиотека · European journal of endocrinology · 2019

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima Akiyuki, Sone Masakatsu, Inagaki Nobuya, Takeda Yoshiyu, Itoh Hiroshi, Kurihara Isao, Umakoshi Hironobu, Ichijo Takamasa, Katabami Takuyuki, Wada Norio, Ogawa Yoshihiro, Kawashima Junji, Fujita Megumi, Miyauchi Shozo, Okamura Shintaro, Fukuoka Tomikazu, Yanase Toshihiko, Izawa Shoichiro, Yoshikawa Yuichiro, Hashimoto Shigeatsu, Yamada Masanobu, Kai Tatsuya, Suzuki Tomoko, Naruse Mitsuhide

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Several clinical studies have reported that renal impairments are sometimes observed in patients with primary aldosteronism (PA). We analyzed the prevalence of renal impairments in PA patients and identified parameters that increase the risk for them.

DESIGN

This is a retrospective cross-sectional study. We assessed the PA database established by the multicenter Japan PA study (JPAS). Data were also collected from patients with essential hypertension (EHT).

METHODS

We compared the prevalences of proteinuria and lowered estimated glomerular filtration rate (eGFR) between patients with PA and age, sex, blood pressure and duration of hypertension-matched patients with EHT. We also performed logistic regression analysis to identify parameters that increase the risk for these renal impairments.

RESULTS

Among 2366 PA patients, the prevalences of proteinuria and lowered eGFR were 10.3 and 11.6%, respectively. The prevalence of proteinuria was significantly higher in PA patients than matched-EHT patients (16.8 vs 4.4%), whereas there was no significant difference in the prevalence of lowered eGFR (17.2 vs 15.0%). The logistic regression analysis also showed that the plasma aldosterone concentration (PAC) significantly increases the risk of proteinuria and lowered eGFR, independent of other known risk factors.

CONCLUSION

Plasma aldosterone levels are closely associated with renal impairment in patients with PA. This is contrast to our earlier finding that the PAC was not itself linearly associated with cardiovascular events such as stroke or ischemic heart disease. The mechanism underlying the kidney damage in patients with PA may differ from that affecting the cardiovascular system.

Для цитирования: Kawashima Akiyuki, Sone Masakatsu, Inagaki Nobuya, Takeda Yoshiyu, Itoh Hiroshi, Kurihara Isao, Umakoshi Hironobu, Ichijo Takamasa, Katabami Takuyuki, Wada Norio, Ogawa Yoshihiro, Kawashima Junji, Fujita Megumi, Miyauchi Shozo, Okamura Shintaro, Fukuoka Tomikazu, Yanase Toshihiko, Izawa Shoichiro, Yoshikawa Yuichiro, Hashimoto Shigeatsu, Yamada Masanobu, Kai Tatsuya, Suzuki Tomoko, Naruse Mitsuhide. Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.. European journal of endocrinology. 2019. DOI: 10.1530/eje-19-0047.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.